{"text": "5 deadliest diseases in the u.s. -- and the top drugs potentially #stocks $mrk, $bmy, $alny, $azn, $biib, $mdco URL"}
{"text": "upcoming fda calendar: $mrus $nvs $once $xbit $kpti $nlnk $gsk $mrk $sny $nbix URL"}
{"text": "AT_USER AT_USER AT_USER strategic decision i guess. 1st preference: defend pd1 market share by not falling\u00a1\u00ad URL"}
{"text": "rt AT_USER AT_USER it\u00a1\u00afs interesting to watch $mrk &amp; $bmy go all-in with $incy epacadostat. moving more aggressively than roche\u00a1\u00ad"}
{"text": "AT_USER is this signal that their own anti-ido1 is dead, or they wan't to be in front of the learning curve? $bmy, $incy, $mrk"}
{"text": "rt AT_USER more details on previously announced collaboration investigating #epacadostat and #keytruda $incy $mrk URL"}
{"text": "AT_USER it\u00a1\u00afs interesting to watch $mrk &amp; $bmy go all-in with $incy epacadostat. moving more aggressively than roche w/ $nlnk ido."}
{"text": "from a pure competitive standpoint, $bmy is likely compelled to move ahead in an effort to find a niche or two.\u00a1\u00ad URL"}
{"text": "top buy stocks: $hmy, $jnpr, $mrk, $qcom,$tgt  URL"}
{"text": "more details on previously announced collaboration investigating #epacadostat and #keytruda $incy $mrk URL"}
{"text": "davy asset management ltd decreases position in merck &amp; co., inc. $mrk URL"}
{"text": "merck &amp; co., inc. $mrk stake lowered by b &amp; t capital management dba alpha capital management URL"}
{"text": "merck &amp; co., inc. $mrk receives $67.18 average pt from analysts URL"}
{"text": "merck &amp; co., inc. $mrk stake lowered by b &amp; t capital management dba alpha capital management URL"}
{"text": "arrowpoint asset management llc has $370,000 position in merck &amp; co., inc. $mrk URL"}
{"text": "davy asset management ltd decreases position in merck &amp; co., inc. $mrk URL"}
{"text": "commented on stocktwits: 4 of 5 $mrk $msft $nke $pfe $pg $trv light colored a... URL URL"}
{"text": "merck &amp; co., inc. $mrk receives $67.18 average pt from analysts URL"}
{"text": "merck &amp; co., inc. $mrk receives $67.18 average pt from analysts URL #stocks"}
{"text": "merck &amp; co., inc. $mrk receives $67.18 average pt from analysts URL"}
{"text": "merck &amp; co., inc. $mrk upgraded to \u00a1\u00b0buy\u00a1\u00b1 by vetr inc. URL"}
{"text": "rt AT_USER you can bet ido/pd-1 will be a theme at #aacr17 (newlink &amp; bristol data). $mrk &amp; $incy now have 7 pivotals planned. URL"}
{"text": "rt AT_USER AT_USER  battle for 1l lung dominance begins in mid-2017; by 2h 2018,should have most of pieces fall into place $mrk $bm\u00a1\u00ad"}
{"text": "rt AT_USER lr identified 765 active combo trials that include a pd-1/pd- l1 backbone. $mrk $bmy $celg $azn   $ibb AT_USER unreal nu\u00a1\u00ad"}
{"text": "rt AT_USER AT_USER  battle for 1l lung dominance begins in mid-2017; by 2h 2018,should have most of pieces fall into place $mrk $bm\u00a1\u00ad"}
{"text": "AT_USER  battle for 1l lung dominance begins in mid-2017; by 2h 2018,should have most of pieces fall into place\u00a1\u00ad URL"}
